The latest Novalis Circle symposium, held at the annual Congress of Neurological Surgeons (CNS) meeting, explored the complex biology, longevity and optimal treatment options for benign skull base tumor patients.

Patients who received post-operative radiation therapy (PORT) lived an average of four months longer when compared to patients who had the same disease site, tumor histology and treatment criteria but did not receive PORT, according to research presented at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.

A major factor limiting the scope of magnetoencephalography (MEG) programs worldwide has been the cost and availability of the liquid helium needed to operate these advanced brain mapping systems. With its zero-helium boil-off technology, the Elekta Neuromag Triux nearly eliminates the need for liquid helium refills. Elekta introduced the helium recycling technology at the American Epilepsy Society Meeting, Dec. 5-9 in Seattle.

Siemens Financial Services (SFS) provided a financing package to Pueblo Radiology to support their acquisition of a Siemens Somatom Perspective 64 slice computed tomography (CT) scanner.

Pain, discomfort and magnet displacement were documented in a small medical records review study of patients with cochlear implants (CIs) who underwent magnetic resonance imaging (MRI).

Six members of Strategic Radiology (SR), which is composed of radiology groups representing more than 1,200 radiologists across the country, have selected Norcal Mutual to provide medical professional liability insurance, risk management support and claims handling.

Based on its recent analysis of the medical imaging informatics market, Frost & Sullivan recognized Calgary Scientific Inc. with the 2014 North American Frost & Sullivan Award for Growth Capital Investment Opportunity.

To provide high-quality, evidence-based cancer care throughout South Dakota, Minnesota and other surrounding states, Avera Health and Elekta announced a partnership to deploy Mosaiq oncology information system across the Avera Cancer Institute.

A team of researchers from Inserm led by Paul Hofman made a significant advance in the area of early diagnosis of invasive cancers.

Subscribe Now